Similar Search Results

Productivity costs, time costs and health-related quality of life: a response to the Erasmus Group

Weinstein, Milton C.; Siegel, Joanna E.; Garber, Alan M.; … - In: Health Economics 6 (1997) 5, pp. 505-510

Persistent link: https://www.econbiz.de/10005442783

On being <TOGGLE>NICE</TOGGLE> in the UK: guidelines for technology appraisal for the NHS in England and Wales

Birch, Stephen; Gafni, Amiram - In: Health Economics 11 (2002) 3, pp. 185-191

No Abstract

Persistent link: https://www.econbiz.de/10005200073

Recognizing diversity in public preferences: The use of preference sub-groups in cost-effectiveness analysis

Sculpher, Mark; Gafni, Amiram - In: Health Economics 10 (2001) 4, pp. 317-324

Public preferences are typically incorporated into cost-effectiveness analyses (CEA) on the basis of the average health state utilities of a sample of individuals drawn from the general public. The cost-effectiveness of a programme is then assessed on an 'all-or-nothing' basis: the programme is...

Persistent link: https://www.econbiz.de/10005689828

Recognising diversity in public preferences: the use of preference sub-groups in cost-effectiveness analysis. Authors' reply

Sculpher, Mark; Gafni, Amiram - In: Health Economics 11 (2002) 7, pp. 653-654

No Abstract

Persistent link: https://www.econbiz.de/10005689981

Double discounting of QALYs

MacKeigan, Linda D.; Gafni, Amiram; O'Brien, Bernie J. - In: Health Economics 12 (2003) 2, pp. 165-169

Quality-adjusted life-years (QALYs) calculated from time tradeoff (TTO) based preferences have a time preference component. To impose a conventional discount rate on these implicitly discounted QALYs introduces some degree of double discounting. The purpose of this study was to determine the...

Persistent link: https://www.econbiz.de/10005694096

The distribution problem in economic evaluation: income and the valuation of costs and consequences of health care programmes

Donaldson, Cam; Birch, Stephen; Gafni, Amiram - In: Health Economics 11 (2002) 1, pp. 55-70

To date, a common view in the health economics literature is that the applicability of cost-benefit analysis (CBA) is limited, due to the distribution problem which underlies its main method of valuation (e.g. willingness to pay). One view is that cost effectiveness analysis (CEA) overcomes...

Persistent link: https://www.econbiz.de/10005694125

Health care contingent valuation studies: a review and classification of the literature

Diener, Alan; O'Brien, Bernie; Gafni, Amiram - In: Health Economics 7 (1998) 4, pp. 313-326

<B>Purpose:</B> The contingent valuation method (CVM) is a survey-based approach for eliciting consumer's monetary valuations for programme benefits for use in cost-benefit analysis (CBA). We used the conceptual framework of O'Brien and Gafni (1996) to classify and critically appraise health care CVM...</b>

Persistent link: https://www.econbiz.de/10005694172

UNCERTAINTY AND THE DECISION MAKER: ASSESSING AND MANAGING THE RISK OF UNDESIRABLE OUTCOMES

Gafni, Amiram; Walter, Stephen; Birch, Stephen - In: Health Economics 22 (2013) 11, pp. 1287-1294

Persistent link: https://www.econbiz.de/10010712625